Press Releases

LOS ANGELES--(BUSINESS WIRE)-- Resecurity, Inc. (USA), a Los Angeles-based cybersecurity company protecting major Fortune 500 giants worldwide, proudly announces its recognition as a recipient of the esteemed President's "E Star" Award, the highest recognition any U.S. entity may receive for making a significant contribution to the expansion of U.S. exports, at a ceremony hosted by U.S. Secretary of Commerce Gina M. Raimondo in Washington, D.C. This award... (continue reading...)

David Desharnais, President and COO, appointed as CEO; Viraj Mehta, Chief Investment Officer at Arctis Global, named Executive Director of the Board; Company Founder Robert A. Berman continues as Chairman.

Highlights:

• Q1 2024 gross revenue increased 58% to $9.8 million as compared to $6.2 million in Q1 2023
• Recurring revenue increased 18% to $5.0 million in Q1 2024 as compared to $4.2 million in Q1 2023
• Closed All Traffic Data acquisition in January 2024
• Completed a $26.4... (continue reading...)

Improved cash position with $50 million from acquisition of ElectraMeccanica

Delivered 180% year-over-year revenue growth

Achieved industry-leading 21% gross margins

LOS ANGELES, CA / ACCESSWIRE / May 15, 2024 / Xos, Inc. (NASDAQ: XOS) ("Xos" or the "Company"), a leading electric truck manufacturer and fleet services provider, today reported financial results for the first quarter ended March 31, 2024.

First Quarter 2024 Highlights:

• Completed acquisition of... (continue reading...)

FAIRFAX, VA / ACCESSWIRE / May 15, 2024 / WidePoint Corporation (NYSE American:WYY), the innovative enterprise cyber security and mobile technology provider, reported results for the first quarter ended March 31, 2024.

First Quarter 2024 and Recent Operational Highlights:

• Selected by the U.S. Navy as one of seven contractors for the 10-Year, $2.7 billion Spiral 4 contract
• Awarded more than 18 contractual actions resulting in approximately $22.7 million in contract value in... (continue reading...)

Q3 2024 ADHD Portfolio net revenue up 49% compared to Q3 2023

Q3 2024 adjusted EBITDA 1 improved by $7.0 million compared to Q3 2023

TTM March 2024 operating income of $7.3 million for the Rx Business

TTM March 2024 companywide adjusted EBITDA of positive $15.4 million

TTM March 2024 adjusted EBITDA of positive $17.1 million for the Rx Business

$19.8 million cash balance at March 31, 2024

Company to host conference call and webcast today, May 15, 2024, at 4:30 p.m. Eastern... (continue reading...)